H. Meurs (Groningen, Netherlands), M. Belvisi (London, United Kingdom)
Hydrogen sulfide inhibits cell proliferation and induces cell cycle arrest in airway smooth muscle cells
Y. Chen, P. Wang, Y. Qi, W. Yao, C. Tang (Beijing, China)
|  |
The role of isoprenylation in lipopolysaccharide (LPS)-induced human airway hyperresponsiveness
M. G. Matera, L. Calzetta, A. Comandini, E. Stirpe, M. Cazzola (Rome, Italy)
|  |
Cilomilast counteracts the effects of cigarette smoke in innate immunity responses of airway epithelial cells
E. Pace, M. Ferraro, C. G. Uasuf, A. Giarratano, S. La Grutta, G. Liotta, M. Johnson, M. Gjomarkaj (Palermo, Italy; Greenford, United Kingdom)
| |
Effect of verapamil on bronchial goblet cells of asthma
M. Mirsadraee, M. R. Khakzad, A. Mohammadpour, K. Ghafarzadegan (Mashhad, Islamic Republic Of Iran)
| |
Protective effect of a Protein Epitope Mimetic (PEM) CXCR4 antagonist, POL5551, in an allergic model of asthma
F. Daubeuf, B. Romagnoli, E. Chevalier, N. Frossard (Illkirch, France; Allschwil, Switzerland)
| |
Control of mucus hypersecretion by small polycationic peptides
K. C. Kim (Philadelphia, United States Of America)
| |
Ceramide-1-phosphate decreases allergic airway inflammation, remodeling and hyperresponsiveness by inhibition of phosphorilation of NF-kappa B, Akt, MAPK p-38 in dendritic cells
R. de Paula Vieira, T. Müller, A. Manohara, M. Grimm, S. Cicko, T. Dürk, S. Sorichter, M. Idzko (Germany)
| |
Efficacy of UR-63325, a new H4 receptor antagonist, in two rodent asthma models
S. Sánchez-Gómez, J. Alfón, N. Ardanaz, B. Gil-Torregrosa, A. Fernández, E. Carceller, L. Gómez, D. Balsa, X. Bartrolí, M. Merlos (Palau-solità i Plegamans, Spain)
| |
In vitro pharmacological profile of SMP-028, a novel potent anti-inflammatory agent
J. Hidaka, M. Yamamoto, T. Uda, T. Nakajima, F. Nishikaku, Y. Ueda, M. N. Itoh (Osaka, Japan)
| |
Sirtuins inhibition modulates endotoxin-induced lung inflammation
C. Fernandes, L. Fievez, F. Bureau, R. Vanbever (Brussels, Liège, Belgium)
| |
Chronic inhalation toxicity study of nebulized alpha1 proteinase inhibitor (alpha1-PI), TAL6005, in rodents
V. Arora, K. Bergstrand, J. Price, J. M. Cullen, S. R. Petteway, P. Scuderi (Research Triangle Park, Raleigh, United States Of America)
| |
Lung-epithelial C/EBPβ plays a role in the effects of budesonide and formoterol on the inflammatory response to LPS in vivo
A. Roos, J. Barton, B. Dahlberg, M. Nord, L. Didon (Stockholm, Sweden; Leeds, United Kingdom; New York, United States Of America)
| |
Small neutralizing molecules to inhibit actions of the chemokine CXCL12 and other chemokines
J. L. Galzi, M. Hachet-Haas, N. Frossard, M. Hibert, F. Daubeuf, P. Gizzi, D. Bonnet (Illkirch, France)
| |
Effects of corticosteroid or montelukast associated to iNOS inhibition on inflammation and remodelling of distal lung in animals with chronic inflammation
F. C. R. Souza, N. B. Gobbato, S. B. N. Fumagalli, A. P. Z. Cherubim, B. D. A. Vieira, F. G. Reis, C. M. Starling, C. M. Prado, M. A. Martins, E. A. Leick-Maldonado, I. F. L. C. Tibério (São Paulo, Diadema, Brazil)
| |
Selective PDE inhibitors in modulation of cough reflex and bronchoconstriction in healthy and ovalbumin-sensitized guinea pigs
J. Mokry, G. Nosalova, D. Mokra (Martin, Slovakia)
| |
Cough reflex sensitivity in a model of inflammatory lung disease
S. Maher, J. Nasra, M. Grace, M. Birrell, M. Belvisi (London, United Kingdom)
| |
The effect of leukotrienes and their receptor antagonists on calcium signalling in the cough receptors transient receptor potential ankyrin 1 (TRPA1) and vanilloid 1 (TRPV1)
L. Sadofsky, A. Morice (United Kingdom)
| |
The cannabinoid receptor agonist, WIN 55,212-2, inhibits antigen-induced plasma extravasation in guinea pig airways
H. Fukuda, S. Yoshihara, T. Abe, O. Arisaka (Shimotsuga-gun, Japan)
| |